ReproCELL Incorporated (4978.T)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. Shuji Yokoyama Ph.D. | CEO, President & Representative Director | -- | -- | 1968 |
| Mr. Daisuke Usui | COO & Director | -- | -- | 1973 |
| Mr. Ramakrishna V. Modali | CEO of REPROCELL USA Ltd & CEO of Bioserve Biotechnologies India | -- | -- | -- |
| Dr. David Bunton | Chief Executive officer of REPROCELL Europe | -- | -- | -- |
ReproCELL Incorporated
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 92
Description
ReproCELL Incorporated provides stem cell research and drug discovery services in Japan. It offers stem cell reagents, including RNA reprogramming, small molecules, growth factors and cytokines, antibodies and staining kits, cell substrates, cryopreservation media, dissociation solution, and transfection reagents; differentiated induced pluripotent stem cell (iPSC) and related reagents, feeder cells, pluripotent stem cells, and synfire induced neurons; 3D cell culture; and labware. The company also provides research stem cell, genomics, clinical stem cell research, preclinical and drug discovery CRO, precision medicine, human tissue samples, clinical laboratory, diagnostic, and gene editing services. ReproCELL Incorporated was incorporated in 2003 and is based in Yokohama, Japan.
Corporate Governance
Recent Events
Recent Events Information Not Available